We respect your privacy. Please consent to all cookies when you visit our website. Refer to our "Privacy Policy" for more information on how we handle personal data.

EN
  • 01-2.png
CE|ANVISA|NMPA Registration No. 20213400828

Influenza A / Influenza B Virus Nucleic Acid Detection Kit(Fluorescent PCR Method)

  • Multiplex Differentiation

    Single-tube amplification assay, differentiating Influenza A and Influenza B

  • Excellent Detection Performance

    Sensitivity of 1,000 copies/mL, with strong specificity and high precision

  • Fast and Easy to Use

    Easy operation, reports in as fast as 30 minutes, meeting the needs of patients for rapid diagnosis

  • Reliable Results

    Includes an internal control to monitor sampling, extraction and detection processes, ensuring reliable results.

  • Open Platform Compatibility

    Compatible with commonly used real-time PCR instruments on the market, with no need to purchase additional equipment

  • Early Diagnosis

    Helps avoid interference from the immunological window period and supports early clinical diagnosis, enabling timely antiviral treatment, reducing the risk of severe disease, lowering mortality and shortening hospital stays.

image.png